Cargando…

Thirty percent of children and young adults with familial hypercholesterolemia treated with statins have adherence issues

OBJECTIVE: To assess adherence to lipid lowering therapy (LLT), reasons for poor adherence, and achievement of LDL-C treatment goals in children and young adults with familial hypercholesterolemia (FH). METHODS: Retrospective review of the medical records of 438 children that started follow-up at th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Langslet, Gisle, Johansen, Anja K., Bogsrud, Martin P., Narverud, Ingunn, Risstad, Hilde, Retterstøl, Kjetil, Holven, Kirsten B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315460/ https://www.ncbi.nlm.nih.gov/pubmed/34327501 http://dx.doi.org/10.1016/j.ajpc.2021.100180

Ejemplares similares

Young women with familial hypercholesterolemia have higher LDL-cholesterol burden than men: Novel data using repeated measurements during 12-years follow-up
por: Johansen, Anja K., et al.
Publicado: (2023)

Data on circulating leukocyte subpopulations and inflammatory proteins in children with familial hypercholesterolemia and healthy children
por: Christensen, Jacob J., et al.
Publicado: (2016)

Association of Familial Hypercholesterolemia and Statin Use With Risk of Dementia in Norway
por: Mundal, Liv J., et al.
Publicado: (2022)

The risk of various types of cardiovascular diseases in mutation positive familial hypercholesterolemia; a review
por: Hovland, Anders, et al.
Publicado: (2022)

Gender differences in nutrition literacy levels among university students and employees: a descriptive study
por: Svendsen, Karianne, et al.
Publicado: (2021)

Lower risk of smoking-related cancer in individuals with familial hypercholesterolemia compared with controls: a prospective matched cohort study
por: Krogh, Henriette W., et al.
Publicado: (2019)

Risk of Recurrent Coronary Events in Patients With Familial Hypercholesterolemia; A 10-Years Prospective Study
por: Arnesen, Kjell-Erik, et al.
Publicado: (2021)

Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH children
por: Molven, Ingunn, et al.
Publicado: (2013)

Subjects with Low Plasma HDL Cholesterol Levels Are Characterized by an Inflammatory and Oxidative Phenotype
por: Holven, Kirsten B., et al.
Publicado: (2013)

Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics
por: Retterstøl, Kjetil, et al.
Publicado: (2017)

Substitution of TAG oil with diacylglycerol oil in food items improves the predicted 10 years cardiovascular risk score in healthy, overweight subjects
por: Telle-Hansen, Vibeke H., et al.
Publicado: (2012)

Postprandial changes in gene expression of cholesterol influx and efflux mediators after intake of SFA compared with n-6 PUFA in subjects with and without familial hypercholesterolaemia: secondary outcomes of a randomised controlled trial
por: Øyri, Linn K. L., et al.
Publicado: (2019)

Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
por: Langslet, Gisle, et al.
Publicado: (2020)

Maternal prenatal cholesterol levels predict offspring weight trajectories during childhood in the Norwegian Mother, Father and Child Cohort Study
por: Øyri, Linn K. L., et al.
Publicado: (2023)

Editorial: Genetics of Familial Hypercholesterolemia: New Insight
por: Vuorio, Alpo, et al.
Publicado: (2021)

Editorial: Genetics of familial hypercholesterolemia: New insight—Volume II
por: Vuorio, Alpo, et al.
Publicado: (2022)

Sex Differences in Familial Hypercholesterolemia
por: Klevmoen, Marianne, et al.
Publicado: (2023)

Differential effects of bariatric surgery and lifestyle interventions on plasma levels of Lp(a) and fatty acids
por: Berk, Kirsten A., et al.
Publicado: (2022)

Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies
por: Kastelein, John J. P., et al.
Publicado: (2014)

The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions
por: Ofstad, Anne Pernille, et al.
Publicado: (2018)

Long-Term Statin Treatment in Children with Familial Hypercholesterolemia: More Insight into Tolerability and Adherence
por: Braamskamp, Marjet J. A. M., et al.
Publicado: (2015)

Novel associations between parental and newborn cord blood metabolic profiles in the Norwegian Mother, Father and Child Cohort Study
por: Øyri, Linn K. L., et al.
Publicado: (2021)

Thirty percent conversion efficiency from radiofrequency power to thrust energy in a magnetic nozzle plasma thruster
por: Takahashi, Kazunori
Publicado: (2022)

Lack of Effects of a Single High-Fat Meal Enriched with Vegetable n-3 or a Combination of Vegetable and Marine n-3 Fatty Acids on Intestinal Peptide Release and Adipokines in Healthy Female Subjects
por: Narverud, Ingunn, et al.
Publicado: (2016)

Mortality Among Patients With Familial Hypercholesterolemia: A Registry‐Based Study in Norway, 1992–2010
por: Mundal, Liv, et al.
Publicado: (2014)

Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME(®)
por: Langslet, Gisle, et al.
Publicado: (2020)

Efficacy and Safety of Alirocumab 300 mg Every 4 Weeks in Individuals With Type 2 Diabetes on Maximally Tolerated Statin
por: Müller-Wieland, Dirk, et al.
Publicado: (2019)

Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factors
por: Myhrstad, Mari C. W., et al.
Publicado: (2011)

Fatty acid profile and estimated desaturase activities in whole blood are associated with metabolic health
por: Svendsen, Karianne, et al.
Publicado: (2020)

The combination of Ezetimibe and Statin: a new treatment for hypercholesterolemia
por: NODARI, SAVINA, et al.
Publicado: (2007)

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
por: Hamilton-Craig, Ian, et al.
Publicado: (2010)

The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia
por: Pang, Jing, et al.
Publicado: (2020)

The Benefits Outweigh the Risks of Treating Hypercholesterolemia: The Statin Dilemma
por: Hussain, Azhar, et al.
Publicado: (2023)

Early efficacy and safety of statin therapy in Korean patients with hypercholesterolemia: Daegu and Gyeongbuk Statin Registry
por: Bae, Han Joon, et al.
Publicado: (2020)

Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis
por: Radaelli, Graciane, et al.
Publicado: (2018)

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
por: Laufs, Ulrich, et al.
Publicado: (2019)

Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
por: Vuorio, Alpo, et al.
Publicado: (2021)

Inclisiran adjuvant therapy to statins for the use of hypercholesterolemia: a commentary
por: Vohra, Laiba Imran, et al.
Publicado: (2023)

Bioavailability of n-3 fatty acids from n-3-enriched foods and fish oil with different oxidative quality in healthy human subjects: a randomised single-meal cross-over study
por: Ottestad, Inger, et al.
Publicado: (2016)

The tree of one percent
por: Dagan, Tal, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_10vaif0om5jmc4nrsoq7log3tv